glp-1 parkinson's disease lancet Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Diseases | CNS Drugs GLP-1a: Going beyond Traditional Use

Compounded medications are only indicated for patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product

Patients with severe renal impairment, a history of pancreatitis, or significant gastrointestinal disease should undergo thorough evaluation before starting retatrutide

Not a silver bullet: making nuanced decisions for each patient However, GLP-1RAs are not universally effective for all patients, and Yuan said that even after deciding to prescribe this drug class, physicians should consider multiple factors when selecting a specific drug and dosage

It has not been a major issue, she told Healthline